Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Biopharmaceuticals market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Biopharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by Biopharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis
AbbVie
Roche
Amgen
Johnson & Johnson
Sanofi-Aventis
Eli Lilly
Novo Nordisk
Pfizer
Merck
By Type:
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
By End-User:
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biopharmaceuticals Market
-
1.3 Market Segment by Type
1.3.1 Japan Biopharmaceuticals Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026
1.3.2 Japan Biopharmaceuticals Market Size and Growth Rate of Interferon from 2014 to 2026
1.3.3 Japan Biopharmaceuticals Market Size and Growth Rate of Colony-Stimulating Factor from 2014 to 2026
1.3.4 Japan Biopharmaceuticals Market Size and Growth Rate of Erythropoietin from 2014 to 2026
1.3.5 Japan Biopharmaceuticals Market Size and Growth Rate of Insulin from 2014 to 2026
1.3.6 Japan Biopharmaceuticals Market Size and Growth Rate of Vaccines from 2014 to 2026
1.3.7 Japan Biopharmaceuticals Market Size and Growth Rate of Growth Hormones from 2014 to 2026
1.3.8 Japan Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Biopharmaceuticals Market Size and Growth Rate of Tumor from 2014 to 2026
1.4.2 Japan Biopharmaceuticals Market Size and Growth Rate of Diabetes from 2014 to 2026
1.4.3 Japan Biopharmaceuticals Market Size and Growth Rate of Cardiovascular from 2014 to 2026
1.4.4 Japan Biopharmaceuticals Market Size and Growth Rate of Hemophilia from 2014 to 2026
1.4.5 Japan Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Biopharmaceuticals Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biopharmaceuticals by Major Types
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies
3.4.2 Market Size and Growth Rate of Interferon
3.4.3 Market Size and Growth Rate of Colony-Stimulating Factor
3.4.4 Market Size and Growth Rate of Erythropoietin
3.4.5 Market Size and Growth Rate of Insulin
3.4.6 Market Size and Growth Rate of Vaccines
3.4.7 Market Size and Growth Rate of Growth Hormones
3.4.8 Market Size and Growth Rate of Others
4 Segmentation of Biopharmaceuticals Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biopharmaceuticals by Major End-Users
4.4.1 Market Size and Growth Rate of Biopharmaceuticals in Tumor
4.4.2 Market Size and Growth Rate of Biopharmaceuticals in Diabetes
4.4.3 Market Size and Growth Rate of Biopharmaceuticals in Cardiovascular
4.4.4 Market Size and Growth Rate of Biopharmaceuticals in Hemophilia
4.4.5 Market Size and Growth Rate of Biopharmaceuticals in Others
5 Market Analysis by Regions
-
5.1 Japan Biopharmaceuticals Production Analysis by Regions
-
5.2 Japan Biopharmaceuticals Consumption Analysis by Regions
6 Hokkaido Biopharmaceuticals Landscape Analysis
-
6.1 Hokkaido Biopharmaceuticals Landscape Analysis by Major Types
-
6.2 Hokkaido Biopharmaceuticals Landscape Analysis by Major End-Users
7 Tohoku Biopharmaceuticals Landscape Analysis
-
7.1 Tohoku Biopharmaceuticals Landscape Analysis by Major Types
-
7.2 Tohoku Biopharmaceuticals Landscape Analysis by Major End-Users
8 Kanto Biopharmaceuticals Landscape Analysis
-
8.1 Kanto Biopharmaceuticals Landscape Analysis by Major Types
-
8.2 Kanto Biopharmaceuticals Landscape Analysis by Major End-Users
9 Chubu Biopharmaceuticals Landscape Analysis
-
9.1 Chubu Biopharmaceuticals Landscape Analysis by Major Types
-
9.2 Chubu Biopharmaceuticals Landscape Analysis by Major End-Users
10 Kinki Biopharmaceuticals Landscape Analysis
-
10.1 Kinki Biopharmaceuticals Landscape Analysis by Major Types
-
10.2 Kinki Biopharmaceuticals Landscape Analysis by Major End-Users
11 Chugoku Biopharmaceuticals Landscape Analysis
-
11.1 Chugoku Biopharmaceuticals Landscape Analysis by Major Types
-
11.2 Chugoku Biopharmaceuticals Landscape Analysis by Major End-Users
12 Shikoku Biopharmaceuticals Landscape Analysis
-
12.1 Shikoku Biopharmaceuticals Landscape Analysis by Major Types
-
12.2 Shikoku Biopharmaceuticals Landscape Analysis by Major End-Users
13 Kyushu Biopharmaceuticals Landscape Analysis
-
13.1 Kyushu Biopharmaceuticals Landscape Analysis by Major Types
-
13.2 Kyushu Biopharmaceuticals Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Novartis
14.1.1 Novartis Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 AbbVie
14.2.1 AbbVie Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Roche
14.3.1 Roche Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Amgen
14.4.1 Amgen Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Johnson & Johnson
14.5.1 Johnson & Johnson Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Sanofi-Aventis
14.6.1 Sanofi-Aventis Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Eli Lilly
14.7.1 Eli Lilly Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Novo Nordisk
14.8.1 Novo Nordisk Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Pfizer
14.9.1 Pfizer Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Merck
14.10.1 Merck Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 137 Figures and 159 Tables)
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Interferon from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Colony-Stimulating Factor from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Erythropoietin from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Insulin from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Vaccines from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Growth Hormones from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Tumor from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Diabetes from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Hemophilia from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Biopharmaceuticals Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Biopharmaceuticals
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biopharmaceuticals by Different Types from 2014 to 2026
-
Table Consumption Share of Biopharmaceuticals by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Monoclonal Antibodies
Figure Market Size and Growth Rate of Interferon
Figure Market Size and Growth Rate of Colony-Stimulating Factor
Figure Market Size and Growth Rate of Erythropoietin
Figure Market Size and Growth Rate of Insulin
Figure Market Size and Growth Rate of Vaccines
Figure Market Size and Growth Rate of Growth Hormones
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Biopharmaceuticals by Different End-Users from 2014 to 2026
-
Table Consumption Share of Biopharmaceuticals by Different End-Users from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Tumor from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Diabetes from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Hemophilia from 2014 to 2026
Figure Japan Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan Biopharmaceuticals Production by Regions
-
Table Japan Biopharmaceuticals Production Share by Regions
-
Figure Japan Biopharmaceuticals Production Share by Regions in 2014
-
Figure Japan Biopharmaceuticals Production Share by Regions in 2018
-
Figure Japan Biopharmaceuticals Production Share by Regions in 2026
-
Table Japan Biopharmaceuticals Consumption by Regions
-
Table Japan Biopharmaceuticals Consumption Share by Regions
-
Figure Japan Biopharmaceuticals Consumption Share by Regions in 2014
-
Figure Japan Biopharmaceuticals Consumption Share by Regions in 2018
-
Figure Japan Biopharmaceuticals Consumption Share by Regions in 2026
-
Table Hokkaido Biopharmaceuticals Consumption by Types from 2014 to 2026
-
Table Hokkaido Biopharmaceuticals Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Biopharmaceuticals Consumption Share by Types in 2014
-
Figure Hokkaido Biopharmaceuticals Consumption Share by Types in 2018
-
Figure Hokkaido Biopharmaceuticals Consumption Share by Types in 2026
-
Table Hokkaido Biopharmaceuticals Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Biopharmaceuticals Consumption Share by End-Users in 2014
-
Figure Hokkaido Biopharmaceuticals Consumption Share by End-Users in 2018
-
Figure Hokkaido Biopharmaceuticals Consumption Share by End-Users in 2026
-
Table Tohoku Biopharmaceuticals Consumption by Types from 2014 to 2026
-
Table Tohoku Biopharmaceuticals Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Biopharmaceuticals Consumption Share by Types in 2014
-
Figure Tohoku Biopharmaceuticals Consumption Share by Types in 2018
-
Figure Tohoku Biopharmaceuticals Consumption Share by Types in 2026
-
Table Tohoku Biopharmaceuticals Consumption by End-Users from 2014 to 2026
-
Table Tohoku Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Biopharmaceuticals Consumption Share by End-Users in 2014
-
Figure Tohoku Biopharmaceuticals Consumption Share by End-Users in 2018
-
Figure Tohoku Biopharmaceuticals Consumption Share by End-Users in 2026
-
Table Kanto Biopharmaceuticals Consumption by Types from 2014 to 2026
-
Table Kanto Biopharmaceuticals Consumption Share by Types from 2014 to 2026
-
Figure Kanto Biopharmaceuticals Consumption Share by Types in 2014
-
Figure Kanto Biopharmaceuticals Consumption Share by Types in 2018
-
Figure Kanto Biopharmaceuticals Consumption Share by Types in 2026
-
Table Kanto Biopharmaceuticals Consumption by End-Users from 2014 to 2026
-
Table Kanto Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Biopharmaceuticals Consumption Share by End-Users in 2014
-
Figure Kanto Biopharmaceuticals Consumption Share by End-Users in 2018
-
Figure Kanto Biopharmaceuticals Consumption Share by End-Users in 2026
-
Table Chubu Biopharmaceuticals Consumption by Types from 2014 to 2026
-
Table Chubu Biopharmaceuticals Consumption Share by Types from 2014 to 2026
-
Figure Chubu Biopharmaceuticals Consumption Share by Types in 2014
-
Figure Chubu Biopharmaceuticals Consumption Share by Types in 2018
-
Figure Chubu Biopharmaceuticals Consumption Share by Types in 2026
-
Table Chubu Biopharmaceuticals Consumption by End-Users from 2014 to 2026
-
Table Chubu Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Biopharmaceuticals Consumption Share by End-Users in 2014
-
Figure Chubu Biopharmaceuticals Consumption Share by End-Users in 2018
-
Figure Chubu Biopharmaceuticals Consumption Share by End-Users in 2026
-
Table Kinki Biopharmaceuticals Consumption by Types from 2014 to 2026
-
Table Kinki Biopharmaceuticals Consumption Share by Types from 2014 to 2026
-
Figure Kinki Biopharmaceuticals Consumption Share by Types in 2014
-
Figure Kinki Biopharmaceuticals Consumption Share by Types in 2018
-
Figure Kinki Biopharmaceuticals Consumption Share by Types in 2026
-
Table Kinki Biopharmaceuticals Consumption by End-Users from 2014 to 2026
-
Table Kinki Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Biopharmaceuticals Consumption Share by End-Users in 2014
-
Figure Kinki Biopharmaceuticals Consumption Share by End-Users in 2018
-
Figure Kinki Biopharmaceuticals Consumption Share by End-Users in 2026
-
Table Chugoku Biopharmaceuticals Consumption by Types from 2014 to 2026
-
Table Chugoku Biopharmaceuticals Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Biopharmaceuticals Consumption Share by Types in 2014
-
Figure Chugoku Biopharmaceuticals Consumption Share by Types in 2018
-
Figure Chugoku Biopharmaceuticals Consumption Share by Types in 2026
-
Table Chugoku Biopharmaceuticals Consumption by End-Users from 2014 to 2026
-
Table Chugoku Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Biopharmaceuticals Consumption Share by End-Users in 2014
-
Figure Chugoku Biopharmaceuticals Consumption Share by End-Users in 2018
-
Figure Chugoku Biopharmaceuticals Consumption Share by End-Users in 2026
-
Table Shikoku Biopharmaceuticals Consumption by Types from 2014 to 2026
-
Table Shikoku Biopharmaceuticals Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Biopharmaceuticals Consumption Share by Types in 2014
-
Figure Shikoku Biopharmaceuticals Consumption Share by Types in 2018
-
Figure Shikoku Biopharmaceuticals Consumption Share by Types in 2026
-
Table Shikoku Biopharmaceuticals Consumption by End-Users from 2014 to 2026
-
Table Shikoku Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Biopharmaceuticals Consumption Share by End-Users in 2014
-
Figure Shikoku Biopharmaceuticals Consumption Share by End-Users in 2018
-
Figure Shikoku Biopharmaceuticals Consumption Share by End-Users in 2026
-
Table Kyushu Biopharmaceuticals Consumption by Types from 2014 to 2026
-
Table Kyushu Biopharmaceuticals Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Biopharmaceuticals Consumption Share by Types in 2014
-
Figure Kyushu Biopharmaceuticals Consumption Share by Types in 2018
-
Figure Kyushu Biopharmaceuticals Consumption Share by Types in 2026
-
Table Kyushu Biopharmaceuticals Consumption by End-Users from 2014 to 2026
-
Table Kyushu Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Biopharmaceuticals Consumption Share by End-Users in 2014
-
Figure Kyushu Biopharmaceuticals Consumption Share by End-Users in 2018
-
Figure Kyushu Biopharmaceuticals Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Novartis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
Figure Sales and Growth Rate Analysis of Novartis
Figure Revenue and Market Share Analysis of Novartis
Table Product and Service Introduction of Novartis
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
Figure Sales and Growth Rate Analysis of Roche
Figure Revenue and Market Share Analysis of Roche
Table Product and Service Introduction of Roche
Table Company Profile and Development Status of Amgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
Figure Sales and Growth Rate Analysis of Amgen
Figure Revenue and Market Share Analysis of Amgen
Table Product and Service Introduction of Amgen
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of Sanofi-Aventis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis
Figure Sales and Growth Rate Analysis of Sanofi-Aventis
Figure Revenue and Market Share Analysis of Sanofi-Aventis
Table Product and Service Introduction of Sanofi-Aventis
Table Company Profile and Development Status of Eli Lilly
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
Figure Sales and Growth Rate Analysis of Eli Lilly
Figure Revenue and Market Share Analysis of Eli Lilly
Table Product and Service Introduction of Eli Lilly
Table Company Profile and Development Status of Novo Nordisk
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
Figure Sales and Growth Rate Analysis of Novo Nordisk
Figure Revenue and Market Share Analysis of Novo Nordisk
Table Product and Service Introduction of Novo Nordisk
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Merck
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
Figure Sales and Growth Rate Analysis of Merck
Figure Revenue and Market Share Analysis of Merck
Table Product and Service Introduction of Merck
-
